Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Yourgene Health plc (YGEN) Ordinary Shares 0.1p

Sell:14.50p Buy:15.00p 0 Change: No change
Market closed Prices as at close on 22 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:14.50p
Buy:15.00p
Change: No change
Market closed Prices as at close on 22 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:14.50p
Buy:15.00p
Change: No change
Market closed Prices as at close on 22 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Yourgene Health PLC, formerly Premaitha Health PLC, is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time.

Contact details

Address:
Enterprise House, Lloyd Street North
MANCHESTER
M15 6SE
United Kingdom
Telephone:
+44 (0161) 6676865
Website:
https://www.premaitha.com/

Important dates

Future events
There are no future events available.
Past events
Annual report 01 September 2021 01/09/21
Trading Announcement 11 August 2021 11/08/21
Final results 11 August 2021 11/08/21
Trading Announcement 29 April 2021 29/04/21
Trading Announcement 08 February 2021 08/02/21
Interim results 17 December 2020 17/12/20
Trading Announcement 26 October 2020 26/10/20

General stock information

EPIC:
YGEN
ISIN:
GB00BN31ZD89
Market cap:
£106.76 million
Shares in issue:
723.78 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Lyn Rees
    Chief Executive Officer
  • Stephen Little
    Executive Vice Chairman of the Board
  • Barry Hextall
    Chief Financial Officer, Director
  • Keng Hsu
    Chief Operating Officer
  • Joanne Mason
    Chief Scientific Officer, Director
  • Scott Sargent
    Vice President of Sales North America
  • William Denman
    Executive Director
  • Bill Chang
    Chief Entrepreneur, Director
  • Hayden Jeffreys
    Group Commercial Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.